Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Geovax Labs (NQ: GOVX )

7.320 -1.030 (-12.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 16,409,514
Open 9.200
Bid (Size) 7.210 (10)
Ask (Size) 7.300 (13)
Prev. Close 8.350
Today's Range 7.030 - 9.560
52wk Range 1.090 - 11.18
Shares Outstanding 2,172,309
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Snowflake, GeoVax, Zoom, Target, Tesla: Why These 5 Stocks Are On Investors' Radars Today
On Wednesday, major U.S. indices were positive, with the Dow Jones Industrial Average rising 0.1% to 40,890.49. 
Via Benzinga
Topics Stocks
Exposures US Equities
GeoVax Labs Stock Surges Ahead Of The Close, Shares Remain Volatile: What's Happening?
GeoVax Labs shares popped ahead of the close on Wednesday and continue to bounce around in extended trading following a report suggesting Wayne County confirmed its first case of mpox since 2022. 
Via Benzinga

Performance

YTD
+31.89%
+31.89%
1 Month
+177.27%
+177.27%
3 Month
+333.14%
+333.14%
6 Month
+234.25%
+234.25%
1 Year
-21.09%
-21.09%

More News

Read More
BioMedNewsBreaks — GeoVax Labs Inc. (NASDAQ: GOVX) Enters $8.5M Registered Direct Offering with Institutional Investor
Via Investor Brand Network
Exposures COVID-19
Registration is Now Open for Tribe Public's Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Labs CEO
Via NewMediaWire
GeoVax (GOVX) Stock Pops Ahead of July 18 Catalyst
Via InvestorPlace
GeoVax Stock Is Tumbling Tuesday: What's Going On?
Via Benzinga
GeoVax Labs: Is This Micro-Cap Biotech Stock a Boom or a Bust?
Via MarketBeat
Exposures COVID-19
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Bit Digital Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Virax Biolabs Shares Climb With Mpox Cases: What To Know
Via Benzinga
GeoVax Labs Stock Continues To Surge: What's Going On?
Via Benzinga
Why Xperi Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Are GeoVax Shares Trading Higher Today?
Via Benzinga
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On?
Via Benzinga
GeoVax to Present at the Emerging Growth Conference on August 21, 2024
Via NewMediaWire
Exposures COVID-19
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak
Via Benzinga
GeoVax, SIGA Technologies Shares Soar After WHO Declares Mpox A Global Health Emergency
Via Benzinga
GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board
Via NewMediaWire
Exposures COVID-19
GOVX Stock Earnings: Geovax Labs Beats EPS for Q2 2024
Via InvestorPlace
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
Via NewMediaWire
Exposures COVID-19
Update: GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
Via NewMediaWire
GeoVax Announces Phase 2 Plans for Gedeptin Cancer Therapy Following Clinical Advisory Committee Review
Via NewMediaWire
GeoVax to Report Second Quarter 2024 Financial Results and Provide Corporate Update on August 6, 2024
Via NewMediaWire
GeoVax to Present at the Emerging Growth Conference on July 18, 2024
Via NewMediaWire
Exposures COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.